SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Dongmei Wang, Réjean Couture, Yanguo Hong, Activated microglia in the spinal cord underlies diabetic neuropathic pain, European Journal of Pharmacology, 2014, 728, 59

    CrossRef

  2. 2
    Orly Liberman, Roni Peleg, Pesach Shvartzman, Chronic pain in type 2 diabetic patients: A cross-sectional study in primary care setting, European Journal of General Practice, 2014, 1

    CrossRef

  3. 3
    Axel C. Mühlbacher, Uwe Junker, Christin Juhnke, Edgar Stemmler, Thomas Kohlmann, Friedhelm Leverkus, Matthias Nübling, Chronic pain patients’ treatment preferences: a discrete-choice experiment, The European Journal of Health Economics, 2014,

    CrossRef

  4. 4
    Randhir Singh, Lalit Kishore, Navpreet Kaur, Diabetic peripheral neuropathy: Current perspective and future directions, Pharmacological Research, 2014, 80, 21

    CrossRef

  5. 5
    Matthew T. Knauf, Kelli F. Koltyn, Exercise-Induced Modulation of Pain in Adults With and Without Painful Diabetic Neuropathy, The Journal of Pain, 2014, 15, 6, 656

    CrossRef

  6. 6
    Ken-ichiro Tanaka, Yuki Nakanishi, Shyota Sekino, Megumi Ikegami, Hiroko Ikeda, Junzo Kamei, Fentanyl produces an anti-hyperalgesic effect through the suppression of sodium channels in mice with painful diabetic neuropathy, European Journal of Pharmacology, 2014, 733, 68

    CrossRef

  7. 7
    Magdalena Bujalska-Zadrożny, Anna de Cordé, Karolina Pawlik, Influence of nitric oxide synthase or cyclooxygenase inhibitors on cannabinoids activity in streptozotocin-induced neuropathy, Pharmacological Reports, 2014,

    CrossRef

  8. 8
    Eugen V. Khomula, Anya L. Borisyuk, Viacheslav Y. Viatchenko-Karpinski, Andrea Briede, Pavel V. Belan, Nana V. Voitenko, Nociceptive Neurons Differentially Express Fast and Slow T-Type Ca2+ Currents in Different Types of Diabetic Neuropathy, Neural Plasticity, 2014, 2014, 1

    CrossRef

  9. 9
    Kin Sing Stephen Lee, Jun-Yan Liu, Karen M. Wagner, Svetlana Pakhomova, Hua Dong, Christophe Morisseau, Samuel H. Fu, Jun Yang, Peng Wang, Arzu Ulu, Christina A. Mate, Long V. Nguyen, Sung Hee Hwang, Matthew L. Edin, Alexandria A. Mara, Heike Wulff, Marcia E. Newcomer, Darryl C. Zeldin, Bruce D. Hammock, Optimized Inhibitors of Soluble Epoxide Hydrolase Improve in Vitro Target Residence Time and in Vivo Efficacy, Journal of Medicinal Chemistry, 2014, 57, 16, 7016

    CrossRef

  10. 10
    K.-I. Cheng, H.-C. Wang, Y.-T. Chuang, C.-W. Chou, H.-P. Tu, Y.-C. Yu, L.-L. Chang, C.-S. Lai, Persistent mechanical allodynia positively correlates with an increase in activated microglia and increased P-p38 mitogen-activated protein kinase activation in streptozotocin-induced diabetic rats, European Journal of Pain, 2014, 18, 2
  11. 11
    M.D. Sanna, A. Quattrone, C. Ghelardini, N. Galeotti, PKC-mediated HuD–GAP43 pathway activation in a mouse model of antiretroviral painful neuropathy, Pharmacological Research, 2014, 81, 44

    CrossRef

  12. 12
    Seong-Su Moon, Young-Sil Lee, Prevalence and clinical characteristics of blepharoptosis in patients with diabetes in the Korea National Health and Nutrition Examination Survey (KNHANES) 2009–2010, Endocrine, 2014,

    CrossRef

  13. 13
    Dipika Bansal, Kapil Gudala, Harini Muthyala, Hari Prasad Esam, Ramya Nayakallu, Anil Bhansali, Prevalence and risk factors of development of peripheral diabetic neuropathy in type 2 diabetes mellitus in a tertiary care setting, Journal of Diabetes Investigation, 2014, 5, 5
  14. 14
    Slobodan M. Todorovic, Vesna Jevtovic-Todorovic, Targeting of CaV3.2 T-type calcium channels in peripheral sensory neurons for the treatment of painful diabetic neuropathy, Pflügers Archiv - European Journal of Physiology, 2014, 466, 4, 701

    CrossRef

  15. 15
    A. Jelicic Kadic, M. Boric, S. Kostic, D. Sapunar, L. Puljak, The effects of intraganglionic injection of calcium/calmodulin-dependent protein kinase II inhibitors on pain-related behavior in diabetic neuropathy, Neuroscience, 2014, 256, 302

    CrossRef

  16. 16
    Giuseppe Lauria, Dan Ziegler, Rayaz Malik, Ingemar S. J. Merkies, Stephen G. Waxman, Catharina G. Faber, The Role of Sodium Channels in Painful Diabetic and Idiopathic Neuropathy, Current Diabetes Reports, 2014, 14, 10

    CrossRef

  17. 17
    Carmine Gazzaruso, Adriana Coppola, Omega-3 Fatty Acids in Brain and Neurological Health, 2014,

    CrossRef

  18. 18
    Antoni Sicras, Javier Rejas, Ruth Navarro, Albert Planas, Adding Pregabalin or Gabapentin for the Management of Community-Treated Patients with Painful Diabetic Peripheral Neuropathy: A Comparative Cost Analysis, Clinical Drug Investigation, 2013, 33, 11, 825

    CrossRef

  19. 19
    Junggi Hong, Meredith Barnes, Nathan Kessler, Case study: Use of vibration therapy in the treatment of diabetic peripheral small fiber neuropathy, Journal of Bodywork and Movement Therapies, 2013, 17, 2, 235

    CrossRef

  20. 20
    T.-J. S. Shi, M.-D. Zhang, H. Zeberg, J. Nilsson, J. Grunler, S.-X. Liu, Q. Xiang, J. Persson, K. J. Fried, S. B. Catrina, M. Watanabe, P. Arhem, K. Brismar, T. G. M. Hokfelt, Coenzyme Q10 prevents peripheral neuropathy and attenuates neuron loss in the db-/db- mouse, a type 2 diabetes model, Proceedings of the National Academy of Sciences, 2013, 110, 2, 690

    CrossRef

  21. 21
    Yan Ping Zhang, Chun Yu Song, Yue Yuan, Ariel Eber, Yiliam Rodriguez, Roy C. Levitt, Peter Takacs, Zhe Yang, Ronald Goldberg, Keith A. Candiotti, Diabetic neuropathic pain development in type 2 diabetic mouse model and the prophylactic and therapeutic effects of coenzyme Q10, Neurobiology of Disease, 2013, 58, 169

    CrossRef

  22. 22
    Sergey Lupachyk, Pierre Watcho, Alexander A. Obrosov, Roman Stavniichuk, Irina G. Obrosova, Endoplasmic reticulum stress contributes to prediabetic peripheral neuropathy, Experimental Neurology, 2013, 247, 342

    CrossRef

  23. 23
    Hsinlin T. Cheng, Jacqueline R. Dauch, Michael T. Porzio, Brandon M. Yanik, Wilson Hsieh, A.Gordon Smith, J.Robinson Singleton, Eva L. Feldman, Increased Axonal Regeneration and Swellings in Intraepidermal Nerve Fibers Characterize Painful Phenotypes of Diabetic Neuropathy, The Journal of Pain, 2013, 14, 9, 941

    CrossRef

  24. 24
    Jacqueline R Dauch, Diane E Bender, Lucía A Luna-Wong, Wilson Hsieh, Brandon M Yanik, Zachary A Kelly, Hsinlin T Cheng, Neurogenic factor-induced Langerhans cell activation in diabetic mice with mechanical allodynia, Journal of Neuroinflammation, 2013, 10, 1, 64

    CrossRef

  25. 25
    Jennifer Zenker, Dan Ziegler, Roman Chrast, Novel pathogenic pathways in diabetic neuropathy, Trends in Neurosciences, 2013, 36, 8, 439

    CrossRef

  26. 26
    Hanan Khalil, Painful diabetic neuropathy management, International Journal of Evidence-Based Healthcare, 2013, 11, 1
  27. 27
    Philip Raskin, Cynthia Huffman, Cory Toth, Michael J. Asmus, Michael Messig, Robert J. Sanchez, Lynne Pauer, Pregabalin in Patients With Inadequately Treated Painful Diabetic Peripheral Neuropathy, The Clinical Journal of Pain, 2013, 1

    CrossRef

  28. 28
    Koichi Suehiro, Tomoharu Funao, Yohei Fujimoto, Tokuhiro Yamada, Takashi Mori, Kiyonobu Nishikawa, Relationship between noradrenaline release in the locus coeruleus and antiallodynic efficacy of analgesics in rats with painful diabetic neuropathy, Life Sciences, 2013, 92, 23, 1138

    CrossRef

  29. 29
    Eugen V. Khomula, Viacheslav Y. Viatchenko-Karpinski, Anya L. Borisyuk, Dmytro E. Duzhyy, Pavel V. Belan, Nana V. Voitenko, Specific functioning of Cav3.2 T-type calcium and TRPV1 channels under different types of STZ-diabetic neuropathy, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2013, 1832, 5, 636

    CrossRef

  30. 30
    Yeong-Mi Seo, Won-Hee Choi, The Relationship between Neuropathic Pain and Glycemic Control, Self Management in Type II Diabetes Mellitus Patients, Journal of the Korea Academia-Industrial cooperation Society, 2013, 14, 4, 1774

    CrossRef

  31. 31
    D. Borsook, E. Kalso, Transforming pain medicine: Adapting to science and society, European Journal of Pain, 2013, 17, 8
  32. 32
    Peter Andras, Alina Andras, Type 2 diabetes: A side effect of the adaptation of neurons and fat cells to support increased cognitive performance, Medical Hypotheses, 2013, 80, 2, 176

    CrossRef

  33. 33
    Nathan J. Kessler, Junggi Hong, Whole body vibration therapy for painful diabetic peripheral neuropathy: A pilot study, Journal of Bodywork and Movement Therapies, 2013, 17, 4, 518

    CrossRef

  34. 34
    B. Inceoglu, K. M. Wagner, J. Yang, A. Bettaieb, N. H. Schebb, S. H. Hwang, C. Morisseau, F. G. Haj, B. D. Hammock, Acute augmentation of epoxygenated fatty acid levels rapidly reduces pain-related behavior in a rat model of type I diabetes, Proceedings of the National Academy of Sciences, 2012, 109, 28, 11390

    CrossRef

  35. 35
    Seung-Hyun Ko, Bong-Yun Cha, Diabetic Peripheral Neuropathy in Type 2 Diabetes Mellitus in Korea, Diabetes & Metabolism Journal, 2012, 36, 1, 6

    CrossRef

  36. 36
    Fernando Carlos, Jocelyn Ramírez-Gámez, Héctor Dueñas, Rosa María Galindo-Suárez, Elisa Ramos, Economic evaluation of duloxetine as a first-line treatment for painful diabetic peripheral neuropathy in Mexico, Journal of Medical Economics, 2012, 15, 2, 233

    CrossRef

  37. 37
    Blair H. Smith, Nicola Torrance, Epidemiology of Neuropathic Pain and Its Impact on Quality of Life, Current Pain and Headache Reports, 2012, 16, 3, 191

    CrossRef

  38. 38
    James P. Burke, Robert J. Sanchez, Ashish V. Joshi, Joseph C. Cappelleri, Mahesh Kulakodlu, Rachel Halpern, Health Care Costs in Patients with Painful Diabetic Peripheral Neuropathy Prescribed Pregabalin or Duloxetine, Pain Practice, 2012, 12, 3
  39. 39
    Peter R. Kamerman, Antonia L. Wadley, Catherine L. Cherry, HIV-Associated Sensory Neuropathy: Risk Factors and Genetics, Current Pain and Headache Reports, 2012, 16, 3, 226

    CrossRef

  40. 40
    Roman Stavniichuk, Hanna Shevalye, Hiroko Hirooka, Jerry L. Nadler, Irina G. Obrosova, Interplay of sorbitol pathway of glucose metabolism, 12/15-lipoxygenase, and mitogen-activated protein kinases in the pathogenesis of diabetic peripheral neuropathy, Biochemical Pharmacology, 2012, 83, 7, 932

    CrossRef

  41. 41
    Vincenza Spallone, Marco Lacerenza, Andrea Rossi, Riccardo Sicuteri, Paolo Marchettini, Painful Diabetic Polyneuropathy, The Clinical Journal oF Pain, 2012, 28, 8, 726

    CrossRef

  42. You have free access to this content42
    Athina Vadalouca, Efklidis Raptis, Eleni Moka, Panagiotis Zis, Panagiota Sykioti, Ioanna Siafaka, Pharmacological Treatment of Neuropathic Cancer Pain: A Comprehensive Review of the Current Literature, Pain Practice, 2012, 12, 3
  43. 43
    Sarka Divisova, Eva Vlckova, Maria Hnojcikova, Miroslav Skorna, Martin Nemec, Petr Dubovy, Ladislav Dusek, Jiri Jarkovsky, Jana Belobradkova, Josef Bednarik, Prediabetes/early diabetes-associated neuropathy predominantly involves sensory small fibres, Journal of the Peripheral Nervous System, 2012, 17, 3
  44. 44
    Mustafa Nazıroğlu, Döndü Merve Dikici, Şeyda Dursun, Role of Oxidative Stress and Ca2+ Signaling on Molecular Pathways of Neuropathic Pain in Diabetes: Focus on TRP Channels, Neurochemical Research, 2012, 37, 10, 2065

    CrossRef

  45. 45
    Jeffrey S. Kroin, Asokumar Buvanendran, Kenneth J. Tuman, James M. Kerns, Safety of Local Anesthetics Administered Intrathecally in Diabetic Rats, Pain Medicine, 2012, 13, 6
  46. 46
    Jian-e Yan, Wei Yuan, Xiaoli Lou, Tao Zhu, Streptozotocin-induced diabetic hyperalgesia in rats is associated with upregulation of toll-like receptor 4 expression, Neuroscience Letters, 2012, 526, 1, 54

    CrossRef

  47. 47
    Jianguo Cheng, Anuj Daftari, Lan Zhou, Sympathetic Blocks Provided Sustained Pain Relief in a Patient with Refractory Painful Diabetic Neuropathy, Case Reports in Anesthesiology, 2012, 2012, 1

    CrossRef

  48. 48
    Bhaskar Reddy Kusuma, Liang Zhang, Teather Sundstrom, Laura B. Peterson, Rick T. Dobrowsky, Brian S. J. Blagg, Synthesis and Evaluation of Novologues as C-Terminal Hsp90 Inhibitors with Cytoprotective Activity against Sensory Neuron Glucotoxicity, Journal of Medicinal Chemistry, 2012, 55, 12, 5797

    CrossRef

  49. 49
    Amir Hashemi Me, Khosro Keshavarz, Zahra Gharibnase, Shekoufeh Nikfar, Mohammad Abdollahi, The Effectiveness and Cost-effectiveness of Pregabalin in the Treatment of Diabetic Peripheral Neuropathy: A Systematic Review and Economic Model, International Journal of Pharmacology, 2012, 8, 6, 490

    CrossRef

  50. 50
    Silvio E. Inzucchi, Robert S. Sherwin, Goldman's Cecil Medicine, 2012,

    CrossRef

  51. 51
    The Cat, 2012,

    CrossRef

  52. 52
    Silvio E. Inzucchi, Robert S. Sherwin, Goldman's Cecil Medicine, 2012,

    CrossRef

  53. 53
    Ya-Hong Gong, Xue-Rong Yu, Hui-Li Liu, Nan Yang, Ping-Ping Zuo, Yu-Guang Huang, Antinociceptive effects of combination of Tramadol and Acetaminophen on painful diabetic neuropathy in streptozotocin-induced diabetic rats, Acta Anaesthesiologica Taiwanica, 2011, 49, 1, 16

    CrossRef

  54. 54
    Michael Ragé, Nathalie Acker, Michiel W. M. Knaapen, Maarten Timmers, Johannes Streffer, Michel P. Hermans, Christian Sindic, Theo Meert, Léon Plaghki, Asymptomatic small fiber neuropathy in diabetes mellitus: investigations with intraepidermal nerve fiber density, quantitative sensory testing and laser-evoked potentials, Journal of Neurology, 2011, 258, 10, 1852

    CrossRef

  55. 55
    Junggi Hong, Meredith J. Barnes, Nathan J. Kessler, Case study: Use of vibration therapy in the treatment of diabetic peripheral small fiber neuropathy, International Journal of Diabetes Mellitus, 2011,

    CrossRef

  56. 56
    Julie V. Berger, Liesbeth Knaepen, Sofie P.M. Janssen, Robby J.P. Jaken, Marco A.E. Marcus, Elbert A.J. Joosten, Ronald Deumens, Cellular and molecular insights into neuropathy-induced pain hypersensitivity for mechanism-based treatment approaches, Brain Research Reviews, 2011, 67, 1-2, 282

    CrossRef

  57. 57
    M. M. Jack, J. M. Ryals, D. E. Wright, Characterisation of glyoxalase I in a streptozocin-induced mouse model of diabetes with painful and insensate neuropathy, Diabetologia, 2011, 54, 8, 2174

    CrossRef

  58. 58
    Xue-Hong Cao, Hee Sun Byun, Shao-Rui Chen, Hui-Lin Pan, Diabetic neuropathy enhances voltage-activated Ca2+ channel activity and its control by M4 muscarinic receptors in primary sensory neurons, Journal of Neurochemistry, 2011, 119, 3
  59. 59
    Andrea M. Vincent, Brian C. Callaghan, Andrea L. Smith, Eva L. Feldman, Diabetic neuropathy: cellular mechanisms as therapeutic targets, Nature Reviews Neurology, 2011, 7, 10, 573

    CrossRef

  60. 60
    Yuzhou Guan, Xinsheng Ding, Yan Cheng, Dongsheng Fan, Lan Tan, Yongjun Wang, Zhongxin Zhao, Zhen Hong, Dong Zhou, Xiaoping Pan, Shengdi Chen, Andrew Martin, Haiyun Tang, Liying Cui, Efficacy of Pregabalin for Peripheral Neuropathic Pain: Results of an 8-Week, Flexible-Dose, Double-Blind, Placebo-Controlled Study Conducted in China, Clinical Therapeutics, 2011, 33, 2, 159

    CrossRef

  61. 61
    Marta Lucchetta, Costanza Pazzaglia, Luca Padua, Chiara Briani, Exploring neuropathic symptoms in a large cohort of Italian patients with different peripheral nervous system diseases, Neurological Sciences, 2011, 32, 3, 423

    CrossRef

  62. 62
    Jana Koroschetz, Stefanie E Rehm, Ulrich Gockel, Mathias Brosz, Rainer Freynhagen, Thomas R Tölle, Ralf Baron, Fibromyalgia and neuropathic pain - differences and similarities. A comparison of 3057 patients with diabetic painful neuropathy and fibromyalgia, BMC Neurology, 2011, 11, 1, 55

    CrossRef

  63. 63
    Nicholas K. Tentolouris, Pain: Painful diabetic neuropathy—new choice of first-line therapy?, Nature Reviews Endocrinology, 2011, 7, 7, 381

    CrossRef

  64. 64
    Sergey Lupachyk, Hanna Shevalye, Yury Maksimchyk, Viktor R. Drel, Irina G. Obrosova, PARP inhibition alleviates diabetes-induced systemic oxidative stress and neural tissue 4-hydroxynonenal adduct accumulation: Correlation with peripheral nerve function, Free Radical Biology and Medicine, 2011, 50, 10, 1400

    CrossRef

  65. 65
    Sherwyn Schwartz, Mila Etropolski, Douglas Y. Shapiro, Akiko Okamoto, Robert Lange, Juergen Haeussler, Christine Rauschkolb, Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial, Current Medical Research and Opinion, 2011, 27, 1, 151

    CrossRef

  66. 66
    Ahmet Dogrul, Husamettin Gul, Ozgur Yesilyurt, Umit H. Ulas, Oguzhan Yildiz, Systemic and spinal administration of etanercept, a tumor necrosis factor alpha inhibitor, blocks tactile allodynia in diabetic mice, Acta Diabetologica, 2011, 48, 2, 135

    CrossRef

  67. 67
    Chris Pasero, Tapentadol for Multimodal Pain Management, Journal of PeriAnesthesia Nursing, 2011, 26, 5, 343

    CrossRef

  68. 68
    Babette Kögel, Jean De Vry, Thomas M. Tzschentke, Thomas Christoph, The antinociceptive and antihyperalgesic effect of tapentadol is partially retained in OPRM1 (μ-opioid receptor) knockout mice, Neuroscience Letters, 2011, 491, 2, 104

    CrossRef

  69. You have free access to this content69
    S.-H. Ko, H.-S. Kwon, J.-M. Yu, S.-H. Baik, I.-B. Park, J.-H. Lee, K.-S. Ko, J.-H. Noh, D.-S. Kim, C.-H. Kim, J.-O. Mok, T.-S. Park, H.-S. Son, B.-Y. Cha, Comparison of the efficacy and safety of tramadol/acetaminophen combination therapy and gabapentin in the treatment of painful diabetic neuropathy, Diabetic Medicine, 2010, 27, 9
  70. 70
    Pierre Watcho, Roman Stavniichuk, David M. Ribnicky, Ilya Raskin, Irina G. Obrosova, High-Fat Diet-Induced Neuropathy of Prediabetes and Obesity: Effect of PMI-5011, an Ethanolic Extract ofArtemisia dracunculusL., Mediators of Inflammation, 2010, 2010, 1

    CrossRef

  71. 71
    Jeffrey S. Kroin, Asokumar Buvanendran, Dana K. Williams, Brian Wagenaar, Mario Moric, Kenneth J. Tuman, James M. Kerns, Local Anesthetic Sciatic Nerve Block and Nerve Fiber Damage in Diabetic Rats, Regional Anesthesia and Pain Medicine, 2010, 35, 4, 343

    CrossRef

  72. 72
    Kristin Ørstavik, Ellen Jørum, Microneurographic findings of relevance to pain in patients with erythromelalgia and patients with diabetic neuropathy, Neuroscience Letters, 2010, 470, 3, 180

    CrossRef

  73. 73
    Mohamed Reda Halawa, Abdullah Karawagh, Anwar Zeidan, Alaa-El-Dine H. Mahmoud, Medhat Sakr, Ahmed Hegazy, Prevalence of painful diabetic peripheral neuropathy among patients suffering from diabetes mellitus in Saudi Arabia, Current Medical Research and Opinion, 2010, 26, 2, 337

    CrossRef

  74. 74
    Sherwyn Schwartz, Mila Etropolski, Douglas Y. Shapiro, Akiko Okamoto, Robert Lange, Juergen Haeussler, Christine Rauschkolb, Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial, Current Medical Research and Opinion, 2010, 151

    CrossRef

  75. 75
    Thomas Christoph, Jean De Vry, Thomas M. Tzschentke, Tapentadol, but not morphine, selectively inhibits disease-related thermal hyperalgesia in a mouse model of diabetic neuropathic pain, Neuroscience Letters, 2010, 470, 2, 91

    CrossRef

  76. 76
    Byung-Jo Kim, Nan-Hee Kim, Sin Gon Kim, Hakjae Roh, Ha-Rim Park, Moon-Ho Park, Kun-Woo Park, S. Charles Cho, Yuen T. So, Utility of the cutaneous silent period in patients with diabetes mellitus, Journal of the Neurological Sciences, 2010, 293, 1-2, 1

    CrossRef

  77. 77
    François Chast, 1998–2008 : les « tops » et les « flops » de la lutte contre la douleur, Douleurs : Evaluation - Diagnostic - Traitement, 2009, 10, S51

    CrossRef

  78. 78
    Ralf Baron, Victor Mayoral, Göran Leijon, Andreas Binder, Ilona Steigerwald, Michael Serpell, 5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study, Current Medical Research and Opinion, 2009, 25, 7, 1663

    CrossRef

  79. 79
    Irina G. Obrosova, Diabetic painful and insensate neuropathy: Pathogenesis and potential treatments, Neurotherapeutics, 2009, 6, 4, 638

    CrossRef

  80. 80
    Ralf Baron, Victor Mayoral, Göran Leijon, Andreas Binder, Ilona Steigerwald, Michael Serpell, Efficacy and Safety of 5% Lidocaine (Lignocaine) Medicated Plaster in Comparison with Pregabalin in Patients with Postherpetic Neuralgia and Diabetic Polyneuropathy, Clinical Drug Investigation, 2009, 29, 4, 231

    CrossRef

  81. 81
    Ralf Baron, Victor Mayoral, Göran Leijon, Andreas Binder, Ilona Steigerwald, Michael Serpell, Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy, Current Medical Research and Opinion, 2009, 25, 7, 1677

    CrossRef

  82. 82
    Stefano Tamburin, Giampietro Zanette, Intravenous Immunoglobulin for the Treatment of Diabetic Lumbosacral Radiculoplexus Neuropathy, Pain Medicine, 2009, 10, 8
  83. 83
    R.P. Agrawal, Jitender Goswami, Shreyans Jain, D.K. Kochar, Management of diabetic neuropathy by sodium valproate and glyceryl trinitrate spray: A prospective double-blind randomized placebo-controlled study, Diabetes Research and Clinical Practice, 2009, 83, 3, 371

    CrossRef

  84. 84
    Clare Y. L. Chao, Gladys L. Y. Cheing, Microvascular dysfunction in diabetic foot disease and ulceration, Diabetes/Metabolism Research and Reviews, 2009, 25, 7
  85. 85
    Pedro Schestatsky, Fernando Gerchman, Josep Valls-Solé, Neurophysiological Tools for Small Fiber Assessment in Painful Diabetic Neuropathy (Comment Letter), Pain Medicine, 2009, 10, 3
  86. 86
    Michael I. Weintraub, David N. Herrmann, A. Gordon Smith, Misha M. Backonja, Steven P. Cole, Pulsed Electromagnetic Fields to Reduce Diabetic Neuropathic Pain and Stimulate Neuronal Repair: A Randomized Controlled Trial, Archives of Physical Medicine and Rehabilitation, 2009, 90, 7, 1102

    CrossRef

  87. 87
    Mitra Tavakoli, Rayaz A Malik, Management of painful diabetic neuropathy, Expert Opinion on Pharmacotherapy, 2008, 9, 17, 2969

    CrossRef

  88. 88
    Diabetic Neuropathy,